Europe fares badly when it comes to translating biomedical research into health innovation. The upcoming Innovative Health Initiative aims to improve things, pumping €2.2B into cross-sector projects
Several countries in the south and east of Europe have improved their R&D performance, slightly narrowing the gap with richer member states. But excellence in research and innovation remains concentrated in northern and western strongholds
The Innovative Medicines Initiative is a catalyst, and our research has been a launch pad for vital research infrastructures that will drive innovation long after projects have finished, writes IMI director Pierre Meulien.
The project, to be launched under the international ‘Mission Innovation’ initiative at COP26 in Glasgow this November, will be open to European scientists
Following serial postponements, the Commission releases documents setting out the timelines and scope of €14.7B worth of grants it will award over the next two years
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.